Home > Boards > US Listed > Biotechs > BrainStorm Cell Therapeutics Inc. (BCLI)

Phoenix—Former U.S. Navy pilot Matt Bellina lives with

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
condoe3 Member Profile
 
Followed By 1
Posts 655
Boards Moderated 0
Alias Born 02/02/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 4/3/2020 5:01:27 PM
BrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation Authority GlobeNewswire Inc. - 4/3/2020 6:59:09 AM
David Setboun Joins BrainStorm as Executive Vice President and Chief Operating Officer GlobeNewswire Inc. - 4/1/2020 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/31/2020 7:52:11 AM
BrainStorm Appoints Renowned Distinguished Economist, Prof. Jacob Frenkel, Chairman of the Board of Directors GlobeNewswire Inc. - 3/31/2020 4:00:10 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/18/2020 6:02:58 AM
BrainStorm to Hold a Conference Call to Update Investors on Corporate Steps Taken to Address COVID-19 GlobeNewswire Inc. - 3/16/2020 3:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/13/2020 5:02:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/13/2020 5:02:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/6/2020 5:07:47 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/6/2020 5:05:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/6/2020 4:11:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/6/2020 2:35:41 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 3/6/2020 2:33:28 PM
BrainStorm Cell Therapeutics Raises $10.0 Million in Common Stock Sale at $8.00 Per Share GlobeNewswire Inc. - 3/6/2020 9:25:10 AM
Fifth and Final Site Announced for BrainStorm’s Progressive Multiple Sclerosis Phase 2 Clinical Trial GlobeNewswire Inc. - 2/27/2020 1:00:10 AM
Annual Report (10-k) Edgar (US Regulatory) - 2/18/2020 7:04:06 AM
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2019 GlobeNewswire Inc. - 2/18/2020 7:00:10 AM
BrainStorm’s Chief Operating Officer to Present at Noble Capital Markets’ Sixteenth Annual Investor Conference GlobeNewswire Inc. - 2/17/2020 1:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/15/2020 1:21:39 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/14/2020 5:58:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/14/2020 5:41:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/14/2020 5:41:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/14/2020 5:40:58 PM
BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn® Regulatory Pathway for Approval in ALS GlobeNewswire Inc. - 2/11/2020 6:00:10 AM
condoe3   Tuesday, 02/05/19 11:33:38 PM
Re: None
Post # of 2666 
Phoenix—Former U.S. Navy pilot Matt Bellina lives with amyotrophic lateral sclerosis (ALS), and since the time of his diagnosis in 2014, he had exhausted the treatment options available to him. But he successfully fought for the right to try investigational treatments so that he and others in his situation could have hope. Today, the Goldwater Institute is pleased to learn that Bellina is undergoing treatment for ALS under the federal Right to Try law. The treatment, NurOwn, is currently in Phase 3 trials.

In a Facebook post today, Bellina announced that he began the investigational treatment one month ago. Since his treatment began, he has experienced “increased core strength and coordination,” which now allows him to pull himself up to standing. Additionally, he has seen “subjective improvement” in his speech and swallowing. “I have been given a gift,” Bellina wrote of his treatment. “Because this is an investigational therapy we don’t know what tomorrow will bring but for now we are feeling incredibly blessed,” he continued.

https://goldwaterinstitute.org/article/former-navy-pilot-with-als-receives-treatment-under-federal-right-to-try-law/

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist